Possible adverse effects of immunotherapy in non-small cell lung cancer; treatment and follow-up of three cases

In the past decade novel agents are on the market for non-small cell lung cancer adenocarcinoma based on pharmacogenomics. The epidermal growth factor receptor mutation, anaplastic lymphoma kinase and programmed death-ligand 1 investigation is necessary in the everyday clinical practice for the onco...

Descripción completa

Detalles Bibliográficos
Autores principales: Zarogoulidis, Paul, Chinelis, Panos, Athanasiadou, Anastasia, Tsiouda, Theodora, Trakada, Georgia, Kallianos, Anastasios, Veletza, Lemonia, Hatzibougias, Dimitris, Mihalopoulou, Electra, Goupou, Eirini, Kosmidis, Christoforos, Sardeli, Chrysanthi, Huang, Haidong, Hohenforst-Schmidt, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519224/
https://www.ncbi.nlm.nih.gov/pubmed/28752057
http://dx.doi.org/10.1016/j.rmcr.2017.07.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519224/
https://www.ncbi.nlm.nih.gov/pubmed/28752057
http://dx.doi.org/10.1016/j.rmcr.2017.07.004

Ejemplares similares